http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018090625-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f905c88c81a7de85531801a97f5f0739
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
filingDate 2018-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8d8b02923456a7458621ca6b2cb4735
publicationDate 2018-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2018090625-A
titleOfInvention Angiotensin in the treatment of brain conditions
abstract Angiotensin is provided in the treatment of brain conditions. The present invention provides, among other things, methods and compositions for treating brain conditions. In some embodiments, the method comprises administering an angiotensin (1-7) peptide to a subject suffering from or susceptible to a brain condition by either the intravenous or subcutaneous route of administration. including. In some embodiments, systemic administration suitable for the present invention is intravenous administration. In some embodiments, systemic administration suitable for the present invention is subcutaneous administration. In some embodiments, systemic administration suitable for the present invention is oral administration. [Selection figure] None
priorityDate 2012-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008546811-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012502071-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466095821
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426402408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9851724

Total number of triples: 28.